
CMS (867.HK/8A8.SG): Ruxolitinib Phosphate Cream Obtained China NDA Approval, Becoming The First and Only Targeted Drug for Vitiligo in China
SHENZHEN, Jan 30, 2026 – ( […]

Moscow, Russia – Janu […]

In Collaboration with MAGO Moon […]

Commences building an RWA (Real- […]

Mexico City, Mexico – […]
London, United Kingdom &nda […]

Introduction In the fourth quart […]

On December 3 local time, an inf […]

The King of the Monsters Becomes […]

New York, NY – Decemb […]

Seoul, Korea – Decemb […]

Seoul, Korea – Decemb […]